IMPROVE: Improving anxiety treatment by Modulating emotional memories PRiOr to in Vivo Exposure: A randomized controlled trial. - IMPROVE - Modulating emotional memories: a RCT

niversiteit Utrecht0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年4月15日

适应症

试验速览

暂无简介。

•- Patients of >18 years of age
•- Sufficient mastery of the Dutch language to complete questionnaires
•- Ability to understand questionnaires and written informed consent
•- Meeting DSM-5 criteria for primary panic disorder (with or without
•agoraphobia) (assessed with MINI-S-DSM-5)
•- Stable medication for at least six weeks and willingness by the patient and
•physician to keep the medication stable during the study period (until FU1).
•The use of sedating medication (e.g. benzodiazepines) is no contraindication,
•however participants are strongly advised not to use sedating medication prior
•to- or after treatment sessions and subsequent days. Use of sedating medication
•will be registered
•- Willingness and ability not to be under the influence of alcohol or drugs
•twenty-four hours before and after each session, general use will be
•discouraged as much as possible

•- Neurological disorder
•- Acute or recent history of suicide attempts according to the M.I.N.I. section
•- Self-reported visual or auditory impairments that could hinder treatment
•- Self-reported epilepsy, pregnancy, or heart disease (these are common
•exclusion criteria for using a fear conditioning task, see 8.3.3)
•- Not willing or able to fill in (online) questionnaires.

发起方